Sio Capital Management’s Spruce Biosciences SPRB Stock Holding History

Sio Capital Management’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,040	Closed	-$3.62M	–	80
2021 Q3	$3.62M	Sell	8,040 -590	-7%	-$370K	1.16%	27
2021 Q2	$7.26M	Sell	8,630 -2,208	-20%	-$2.36M	1.8%	17
2021 Q1	$13.5M	Buy	10,838 +2,349	+28%	+$3.61M	2.74%	8
2020 Q4	$15.5M	Buy	+8,489	New	+$14.1M	3.17%	4

Other funds holding SPRB

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sio Capital Management's SPRB Position: Q4 2021 in Review

Sio Capital Management sold out of Spruce Biosciences (SPRB) in Q4 2021, closing a stake of 8,040 shares — an estimated $3.62M sold.

Sio Capital Management first reported a position in SPRB in Q4 2020 and held it in 4 quarters. The position peaked at $15.5M in Q4 2020. 50 funds tracked by Wall St. Rank hold SPRB as of Q4 2021.

Sio Capital Management reported no remaining Spruce Biosciences position as of Q4 2021 after selling out during the quarter.
Sio Capital Management sold 8,040 Spruce Biosciences shares in Q4 2021, an estimated $3.62M.
Sio Capital Management first reported a position in Spruce Biosciences in Q4 2020 and held it in 4 quarters.
Sio Capital Management's Spruce Biosciences position peaked at $15.5M in Q4 2020.
50 funds tracked by Wall St. Rank held Spruce Biosciences as of Q4 2021.

Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.